Covered recipient · General Payments record
NIMISH KANTILAL PATEL
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$3,725.42
- Reported across 197 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $639.35 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $335.01 | 14 |
| Acerta Pharma LLC | $112.89 | 3 |
| ABBVIE INC. | $61.60 | 3 |
| PFIZER INC. | $49.89 | 3 |
| Lilly USA, LLC | $38.19 | 2 |
| Astellas Pharma US Inc | $28.28 | 1 |
| Esperion Therapeutics, Inc. | $13.49 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.86 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105197830 | CMS |
| ABBVIE INC. | $20.57 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105197832 | CMS |
| ABBVIE INC. | $24.17 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105197834 | CMS |
| Astellas Pharma US Inc | $28.28 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139314542 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.99 | 02/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105581622 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.36 | 06/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105714772 | CMS |
| AstraZeneca Pharmaceuticals LP | $82.54 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104770102 | CMS |
| Esperion Therapeutics, Inc. | $13.49 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129450242 | CMS |
| Lilly USA, LLC | $22.16 | 04/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135252777 | CMS |
| Lilly USA, LLC | $16.03 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135289585 | CMS |
| Novo Nordisk Inc | $11.86 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097310841 | CMS |
| Novo Nordisk Inc | $14.91 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096705637 | CMS |
| Novo Nordisk Inc | $15.52 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097177910 | CMS |
| Novo Nordisk Inc | $4.60 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097289137 | CMS |
| Novo Nordisk Inc | $98.04 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096813707 | CMS |
| Novo Nordisk Inc | $3.16 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097603183 | CMS |
| Novo Nordisk Inc | $14.87 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096923982 | CMS |
| Novo Nordisk Inc | $15.70 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096632453 | CMS |
| Novo Nordisk Inc | $11.90 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097478778 | CMS |
| Novo Nordisk Inc | $5.45 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097287264 | CMS |
| Novo Nordisk Inc | $15.94 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097527358 | CMS |
| Novo Nordisk Inc | $104.92 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097086579 | CMS |
| Novo Nordisk Inc | $14.04 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096824414 | CMS |
| Novo Nordisk Inc | $4.10 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096902175 | CMS |
| PFIZER INC. | $20.73 | 01/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130943576 | CMS |
| PFIZER INC. | $14.76 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131153117 | CMS |
| PFIZER INC. | $14.40 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131164316 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.